Nonprofit Gives $800,000 for Melanoma Research in 2009
"The quality of the research proposals we received this year was unparalleled and created a pool of highly competitive applications," said Meenhard Herlyn, D.V.M., D.Sc., co-chair of the MRF's Scientific Advisory Committee and leader of the Oncogenesis Program at the Wistar Institute in Philadelphia. "The MRF awards the grants to applicants with the best combination of scientific merit, appropriately skilled researchers, the greatest likelihood for success and the highest benefit for the melanoma patient community."
"Generous donations made to the MRF are the key to funding these potentially life-saving research programs, and the high quality of grant applications this year is testament to the desperate need for greater research funding," said C. Randy Lomax, chairman of the MRF's board of directors. "It is our hope that by funding these research proposals we move one step closer to new, better treatment options and ultimately a cure for melanoma."
The most deadly type of skin cancer, melanoma can strike people of all ages, all races and both sexes. In 2008, more than 62,000 Americans were expected to be diagnosed with the disease, resulting in an estimated 8,400 deaths.
In its early stages, melanoma can be successfully removed and monitored by regular skin screenings. However, the disease is deadly in its most advanced stages, as few treatment options exist. The median life expectancy for patients with advanced melanoma is less than one year and existing therapies have not improved survival in more than a decade.
To learn more about donating to MRF and its research programs, please visit www.melanoma.org.
Melanoma, the most serious type of skin cancer, is one of the fastest growing cancers in the U.S., and can strike people of all ages, all races and both sexes. In fact, with a one in 50 lifetime risk of developing melanoma, more than 62,000 Americans were expected to be diagnosed with the disease in 2008, resulting in an estimated 8,400 deaths. Melanoma is the most common form of cancer for young adults 25 to 29 years old and the second most common cancer in adolescents and young adults 15 to 29 years old.
About Melanoma Research Foundation
The Melanoma Research Foundation (MRF) is the largest independent, national organization devoted to melanoma in the United States. The Foundation is committed to the support of medical research for finding effective treatments and eventually a cure for melanoma. The MRF also educates patients and physicians about prevention, diagnosis and treatment of melanoma, while acting as an advocate for the melanoma community to raise awareness of this disease and the need for a cure. The MRF Web site is the premier source for melanoma information seekers. More information is available at www.melanoma.org.